Haemonetics Corporation ( HAE) - Stock Earnings
HAE Upcoming earnings
Estimated EPS and revenue columns are available to paid members.
| Date | EPS (actual / est.) | Revenue low (est.) | Revenue (actual / est.) | Revenue high (est.) |
|---|---|---|---|---|
| Nov. 5, 2026, midnight | — / — | — | — / — | — |
HAE Quarterly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2025Q4 | 44.7 million USD | 339.0 million USD |
| 2026Q1 | -20.1 million USD | 346.4 million USD |
| 2026Q2 | 33.0 million USD | 339.4 million USD |
| 2026Q4 Est. | — | — |
| 2027Q1 Est. | — | — |
| 2027Q2 Est. | — | — |
HAE Yearly earnings
Analyst consensus estimates are available to paid members.
| Date | Earnings | Revenue |
|---|---|---|
| 2024 | 117.6 million USD | 1.3 billion USD |
| 2025 | 167.7 million USD | 1.4 billion USD |
| 2026 | 97.3 million USD | 1.3 billion USD |
| 2026 Est. | — | — |
HAE
Price: $121.11
Earnings Per Share: 2.16 USD
P/E Ratio: 42.29
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 121503
Ebitda: 23.3 millionMarket Capitalization: 4.7 billion